These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26566390)

  • 21. Impact of systematic HIV testing on case finding and retention in care at a primary care clinic in South Africa.
    Clouse K; Hanrahan CF; Bassett J; Fox MP; Sanne I; Van Rie A
    Trop Med Int Health; 2014 Dec; 19(12):1411-9. PubMed ID: 25244155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.
    ; Danel C; Moh R; Gabillard D; Badje A; Le Carrou J; Ouassa T; Ouattara E; Anzian A; Ntakpé JB; Minga A; Kouame GM; Bouhoussou F; Emieme A; Kouamé A; Inwoley A; Toni TD; Ahiboh H; Kabran M; Rabe C; Sidibé B; Nzunetu G; Konan R; Gnokoro J; Gouesse P; Messou E; Dohoun L; Kamagate S; Yao A; Amon S; Kouame AB; Koua A; Kouamé E; Ndri Y; Ba-Gomis O; Daligou M; Ackoundzé S; Hawerlander D; Ani A; Dembélé F; Koné F; Guéhi C; Kanga C; Koule S; Séri J; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatounde N; Bleoué G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Assi R; Bakayoko A; Mahassadi A; Attia A; Oussou A; Mobio M; Bamba D; Koman M; Horo A; Deschamps N; Chenal H; Sassan-Morokro M; Konate S; Aka K; Aoussi E; Journot V; Nchot C; Karcher S; Chaix ML; Rouzioux C; Sow PS; Perronne C; Girard PM; Menan H; Bissagnene E; Kadio A; Ettiegne-Traore V; Moh-Semdé C; Kouame A; Massumbuko JM; Chêne G; Dosso M; Domoua SK; N'Dri-Yoman T; Salamon R; Eholié SP; Anglaret X
    N Engl J Med; 2015 Aug; 373(9):808-22. PubMed ID: 26193126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe mental illness at ART initiation is associated with worse retention in care among HIV-infected Ugandan adults.
    Nachega JB; Mutamba B; Basangwa D; Nguyen H; Dowdy DW; Mills EJ; Katabira E; Nakimuli-Mpungu E
    Trop Med Int Health; 2013 Jan; 18(1):53-7. PubMed ID: 23136882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV-infected ugandan adults taking antiretroviral therapy with CD4 counts >200 cells/μL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrhea.
    Campbell JD; Moore D; Degerman R; Kaharuza F; Were W; Muramuzi E; Odongo G; Wetaka M; Mermin J; Tappero JW
    Clin Infect Dis; 2012 Apr; 54(8):1204-11. PubMed ID: 22423133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incorporating loss to follow-up in estimates of survival among HIV-infected individuals in sub-Saharan Africa enrolled in antiretroviral therapy programs.
    Verguet S; Lim SS; Murray CJ; Gakidou E; Salomon JA
    J Infect Dis; 2013 Jan; 207(1):72-9. PubMed ID: 23100567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing retention in care after 12 months of the Pediatric Development Clinic implementation in rural Rwanda: a retrospective cohort study.
    Bayitondere S; Biziyaremye F; Kirk CM; Magge H; Hann K; Wilson K; Mutaganzwa C; Ngabireyimana E; Nkikabahizi F; Shema E; Tugizimana DB; Miller AC
    BMC Pediatr; 2018 Feb; 18(1):65. PubMed ID: 29452576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variation in attrition at subnational level: review of the Botswana National HIV/AIDS Treatment (Masa) programme data (2002-2013).
    Farahani M; Price N; El-Halabi S; Mlaudzi N; Keapoletswe K; Lebelonyane R; Fetogang EB; Chebani T; Kebaabetswe P; Masupe T; Gabaake K; Auld A; Nkomazana O; Marlink R
    Trop Med Int Health; 2016 Jan; 21(1):18-27. PubMed ID: 26485172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effective coverage for antiretroviral therapy in a Ugandan district with a decentralized model of care.
    Scheibe FJ; Waiswa P; Kadobera D; Müller O; Ekström AM; Sarker M; Neuhann HW
    PLoS One; 2013; 8(7):e69433. PubMed ID: 23936015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Favorable Impact of Community Adherence Support Groups on Retention in Care and Viral Suppression Rates Among Persons with HIV Receiving Antiretroviral Therapy in Mozambique.
    De Schacht C; Amorim G; Van Rompaey S; Melo M; Verissimo C; Naftal A; Graves E; Bilhete F; Tique J; Wester CW
    AIDS Res Hum Retroviruses; 2023 Oct; 39(10):525-532. PubMed ID: 36802932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mortality in an antiretroviral therapy programme in Jinja, south-east Uganda: a prospective cohort study.
    Amuron B; Levin J; Birunghi J; Namara G; Coutinho A; Grosskurth H; Jaffar S
    AIDS Res Ther; 2011 Oct; 8():39. PubMed ID: 22018282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High loss to followup and early mortality create substantial reduction in patient retention at antiretroviral treatment program in north-west ethiopia.
    Wubshet M; Berhane Y; Worku A; Kebede Y; Diro E
    ISRN AIDS; 2012; 2012():721720. PubMed ID: 24052883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delivery of Community-based Antiretroviral Therapy to Maintain Viral Suppression and Retention in Care in South Africa.
    Wang M; Violette LR; Dorward J; Ngobese H; Sookrajh Y; Bulo E; Quame-Amaglo J; Thomas KK; Garrett N; Drain PK
    J Acquir Immune Defic Syndr; 2023 Jun; 93(2):126-133. PubMed ID: 36796353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss to follow up after pregnancy among mothers enrolled on the option B+ program in Uganda.
    Kiirya Y; Musoke P; Adobea Odei Obeng-Amoako G; Kalyango J
    Public Health Pract (Oxf); 2021 Nov; 2():100085. PubMed ID: 36101573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The challenges of ending AIDS in Asia: outcomes of the Thai National AIDS Universal Coverage Programme, 2000-2014.
    Chaivooth S; Bhakeecheep S; Ruxrungtham K; Teeraananchai S; Kerr SJ; Teeraratkul A; Sirinirund P; Ongwandee S; Avihingsanon A; Benjarattanaporn P; Phanuphak N; Sungkanuparph S; Mekthon S; Phanuphak P
    J Virus Erad; 2017 Oct; 3(4):192-199. PubMed ID: 29057081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retention and sustained viral suppression in HIV patients transferred to community refill centres in Kinshasa, DRC.
    Moudachirou R; Van Cutsem G; Chuy RI; Tweya H; Senkoro M; Mabhala M; Zolfo M
    Public Health Action; 2020 Mar; 10(1):33-37. PubMed ID: 32368522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes of patients enrolled in an antiretroviral adherence club with recent viral suppression after experiencing elevated viral loads.
    Sharp J; Wilkinson L; Cox V; Cragg C; van Cutsem G; Grimsrud A
    South Afr J HIV Med; 2019; 20(1):905. PubMed ID: 31308966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes and factors affecting mortality and successful tracing among patients lost to follow-up from antiretroviral therapy in Pawi Hospital, Northwest Ethiopia.
    Assemie MA; Leshargie CT; Petrucka P
    Trop Med Health; 2019; 47():52. PubMed ID: 31719791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dispensing antiretrovirals during Covid-19 lockdown: re-discovering community-based ART delivery models in Uganda.
    Zakumumpa H; Tumwine C; Milliam K; Spicer N
    BMC Health Serv Res; 2021 Jul; 21(1):692. PubMed ID: 34256756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of WHO clinical stage for assessing patient eligibility to antiretroviral therapy in a routine health service setting in Jinja, Uganda.
    Jaffar S; Birungi J; Grosskurth H; Amuron B; Namara G; Nabiryo C; Coutinho A
    AIDS Res Ther; 2008 Feb; 5():4. PubMed ID: 18307778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continuum of care among HIV-1 positive patients in a single center in Italy (2007-2017).
    Lagi F; Kiros ST; Campolmi I; Giachè S; Rogasi PG; Mazzetti M; Bartalesi F; Trotta M; Nizzoli P; Bartoloni A; Sterrantino G
    Patient Prefer Adherence; 2018; 12():2545-2551. PubMed ID: 30555224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.